Baxter International Inc. (BAX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Baxter International Inc. (BAX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

30.61

0.11 (0.36%)

At close: Jan 14, 2025, 3:59 PM

30.62

0.05%

After-hours Jan 14, 2025, 07:00 PM EST

undefined% (undefined)

Bid	29.51
Market Cap	15.63B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.25
PE Ratio (ttm)	122.42
Forward PE	n/a
Analyst	Hold

Ask	31.01
Volume	3,537,201
Avg. Volume (20D)	4,243,304
Open	30.65
Previous Close	30.50
Day's Range	30.28 - 30.82
52-Week Range	28.34 - 44.01
Beta	undefined

About BAX

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nu...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Oct 27, 1981

Employees 60,000

Stock Exchange NYSE

Ticker Symbol BAX

Website https://www.baxter.com

Analyst Forecast

According to 10 analyst ratings, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $40, which is an increase of 30.70% from the latest price.

Buy 30.00%

Hold 60.00%

Sell 10.00%

Stock Forecasts

Next Earnings Release

Baxter International Inc. is scheduled to release its earnings on Feb 6, 2025, before market opens.
Analysts project revenue of $2.67B, reflecting a -31.27% YoY shrinking and earnings per share of 0.55, making a -37.50% decrease YoY.

Why Price Moved

2 months ago · Source

-3.88%

Baxter International shares are trading lower afte... Unlock content with Pro Subscription

5 months ago · Source

-6.55%

Baxter shares are trading lower after the company announced a definitive agreement to divest its Vantive Kidney Care segment to Carlyle for $3.8 billion. The stock initially gained following the announcement but has since reversed.

News

3 weeks ago · businesswire.com

Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Jo...

1 month ago · zacks.com

Baxter Stock May Gain Following Five New Injectable Product Launches

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment.

1 month ago · zacks.com

Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?

Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately.

1 month ago · reuters.com

Baxter resumes dialysis solution production at its hurricane-hit facility

Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.

1 month ago · zacks.com

New Strong Sell Stocks for November 29th

BALY, BAX and CENTA have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2024.

1 month ago · zacks.com

New Strong Sell Stocks for November 21st

BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024.

1 month ago · businesswire.com

Baxter to Present at 7th Annual Evercore HealthCONx Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade...

2 months ago · businesswire.com

Baxter to Present at Jefferies London Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade,...

2 months ago · businesswire.com

Baxter to Present at Stifel 2024 Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter'...

2 months ago · businesswire.com

Baxter Declares Quarterly Dividend

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...

2 months ago · seekingalpha.com

Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript

Baxter International Inc. (NYSE:BAX ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Al...

2 months ago · zacks.com

BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline

Baxter reports better-than-expected third-quarter results. However, the company's gross and operating margins contract.

2 months ago · zacks.com

Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree...

2 months ago · zacks.com

Baxter International (BAX) Beats Q3 Earnings Estimates

Baxter International (BAX) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.68 per share a year ago.

2 months ago · reuters.com

Baxter cuts annual profit forecast on hurricane impact

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

2 months ago · businesswire.com

Baxter Reports Third-Quarter 2024 Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the thi...

2 months ago · zacks.com

Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings

BAX's third-quarter results are likely to benefit from a positive pricing impact and new product launches. However, supply-chain issues are likely to have raised expenses in the quarter.

2 months ago · zacks.com

Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Baxter (BAX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...

2 months ago · youtube.com

Kontoor Brands CEO Scott Baxter on Q3 earnings beat

Scott Baxter, Kontoor Brands CEO, joins CNBC's 'The Exchange' to discuss Kontoor's third-quarter earnings beat, the growth of the company through marketing, and more.

2 months ago · reuters.com

Baxter restarts IV solutions manufacturing line

Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related fl...

Load More News